Retinal Diseases

Clinical Trials

Below is a list of Retinal Diseases clinical trials from the clinical trials database at Mayo Clinic.

This list includes only trials about which Mayo researchers choose to publish information. Mayo Clinic may be conducting other trials which are not in this database. Mayo's clinical trials include experimental treatments, often unavailable elsewhere, which frequently lead to improved patient care for people worldwide. Patients should ask their doctor at Mayo about clinical trials appropriate for their situation.

ARET0332, A Study of Unilateral Retinoblastoma With and Without High-Risk Features and the Role of Adjuvant Chemotherapy
Patients are being asked to take part in this study because they have unilateral retinoblastoma. Retinoblastoma is an eye cancer which affects young children and is found in the retinal layer of the eye (the back layer of the eye). Unilateral means the disease is in only one eye.


Why Is This Study Being Done?
The purpose of this study is to collect information about patients who have retinoblastoma in only one eye and have had the eye removed. Based on an exam of the eye that was removed, doctors will try to see if the patient is more likely (at high risk) to have the cancer come back. They also hope to find out whether or not chemotherapy keeps the cancer from coming back in patients who are high risk. Patients whose cancer has not spread to other parts of the body are called low risk. Low risk patients will only have surgery and will be carefully watched by the study doctor to see if the cancer spreads to other parts of the body. The research staff hope this information will help them to better treat retinoblastoma.
Read more